These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33677646)

  • 41. Ectopic overexpression of COTE1 promotes cellular invasion of hepatocellular carcinoma.
    Zhang H; Huang CJ; Tian Y; Wang YP; Han ZG; Li XC
    Asian Pac J Cancer Prev; 2012; 13(11):5799-804. PubMed ID: 23317259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of interleukin-32α promotes invasion by modulating VEGF in hepatocellular carcinoma.
    Zhao WB; Wang QL; Xu YT; Xu SF; Qiu Y; Zhu F
    Oncol Rep; 2018 Mar; 39(3):1155-1162. PubMed ID: 29286122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.
    Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
    Sun W; Dong WW; Mao LL; Li WM; Cui JT; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(19):2913-20. PubMed ID: 23704824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA‑744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12.
    Zhang W; Liu K; Liu S; Ji B; Liu Y
    Oncol Rep; 2018 Dec; 40(6):3585-3592. PubMed ID: 30542724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZNF300 promotes proliferation and migration of hepatocellular carcinoma by upregulating c-MYC gene expression.
    Xiang W; Ni J; Dong L; Zhu G
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102415. PubMed ID: 39018766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
    Cheng Y; Hou T; Ping J; Chen T; Yin B
    J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.